Preface - Additional potential applications of angiotensin converting enzyme inhibitors and of angiotensin II receptor antagonists

被引：0
|
作者：
Molteni, A [1 ]
机构：
[1] Univ Missouri, Dept Pathol, Kansas City, MO 64110 USA
[2] Univ Missouri, Dept Pharmacol, Kansas City, MO 64110 USA
来源：
CURRENT PHARMACEUTICAL DESIGN | 2003年 / 9卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Do angiotensin II receptor antagonists substitute angiotensin converting enzyme inhibitors in the treatment of high blood pressure?
    González-Juanatey, JR
    REVISTA ESPANOLA DE CARDIOLOGIA, 2000, 53 (01): : 4 - 12
  • [22] Angiotensin converting enzyme inhibitors and angiotensin II antagonists as therapy in chronic liver disease
    Vlachogiannakos, J
    Tang, AKW
    Patch, D
    Burroughs, AK
    GUT, 2001, 49 (02) : 303 - 308
  • [23] Endogenous angiotensin II levels and the mechanism of action of angiotensin-converting enzyme inhibitors and angiotensin receptor type 1 antagonists
    Campbell, DJ
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1996, 23 : S125 - S131
  • [24] Antidiabetic mechanisms of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists: beyond the renin-angiotensin system
    Kurtz, TW
    Pravenec, M
    JOURNAL OF HYPERTENSION, 2004, 22 (12) : 2253 - 2261
  • [25] Survival impact of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in head and neck cancer
    Stokes, William A.
    Molina, Elizabeth
    McDermott, Jessica D.
    Morgan, Rustain L.
    Bickett, Thomas
    Fakhoury, Kareem R.
    Amini, Arya
    Karam, Sana D.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2021, 43 (11): : 3255 - 3275
  • [26] Side Effects of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Antagonists: Are We Facing a New Syndrome
    Montoro de Francisco, Ana
    Garcia-Luque, Amelia
    Fernandez, Manuel
    Puerro, Miguel
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (10): : 1552 - 1553
  • [27] Clinical renoprotection trials involving angiotensin II-receptor antagonists and angiotensin-converting-enzyme inhibitors
    Brenner, BM
    Zagrobelny, J
    KIDNEY INTERNATIONAL, 2003, 63 : 77 - 85
  • [28] Screening for the detection of angiotensin-converting enzyme inhibitors, their metabolites, and AT II receptor antagonists
    Maurer, HH
    Kraemer, T
    Arlt, JW
    THERAPEUTIC DRUG MONITORING, 1998, 20 (06) : 706 - 713
  • [29] The Fetal Safety of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
    Moretti, Myla E.
    Caprara, Daniela
    Drehuta, Irina
    Yeung, Emily
    Cheung, Stefanie
    Federico, Lisa
    Koren, Gideon
    OBSTETRICS AND GYNECOLOGY INTERNATIONAL, 2012, 2012
  • [30] RHINITIS ASSOCIATED TO ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN II RECEPTOR BLOCKER
    Burgos-Pimentel, A.
    Montoro de Francisco, A.
    Garcia-Luque, A.
    Chivato-Perez, T.
    Mateos-Galvan, J. M.
    Puerro-Vicente, M.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 57 - 57
12345